When Ed O. went to the ER for shortness of breath and trembling, he never imagined he’d receive a diagnosis of unresectable ...
In this randomized controlled trial, adjuvant therapy with durvalumab led to improved overall and progression-free survival ...
GlobalData on MSN1d
Genprex links with University of Michigan on lung cancer treatmentGenprex has entered an exclusive licensing agreement with the US University of Michigan for lung cancer therapy, Reqorsa.
abp LIVE on MSN6d
Genetic Testing And Lung Cancer: Assessing Risk FactorsLung cancer is the top cause of cancer-related deaths globally, more prevalent in men, and ranks third among women. Both ...
CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of ...
In September, amivantamab (Rybrevant; Johnson & Johnson) received its fourth treatment indication from the FDA to treat ...
NewsVoir Mumbai Maharashtra [India]2 Lung cancer remains one of the most prevalent and deadly cancers globally with approximately 22 million new cases diagnosed annually contributing to 18 of all canc ...
A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients ...
Novotech, the global full-service clinical CRO, has published a new report, Small Cell Lung Cancer: Global Clinical Trial ...
A woman who was diagnosed with stage 4 lung cancer has revealed the biggest lie she was told about the disease, urging others ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback